Solar
Compare Stocks
4 / 10Stock Comparison
PN vs SOL vs ARRY vs CSIQ
Revenue, margins, valuation, and 5-year total return — side by side.
Solar
Solar
Solar
PN vs SOL vs ARRY vs CSIQ — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Solar | Solar | Solar | Solar |
| Market Cap | $10M | $100M | $1.25B | $1.18B |
| Revenue (TTM) | $63M | $71M | $1.21B | $5.60B |
| Net Income (TTM) | $-3M | $-5M | $-67M | $-104M |
| Gross Margin | 10.0% | 33.9% | 22.4% | 18.3% |
| Operating Margin | -4.0% | -49.8% | 4.5% | 0.1% |
| Forward P/E | — | — | 11.7x | — |
| Total Debt | $6M | $63M | $766M | $7.68B |
| Cash & Equiv. | $9M | $50M | $244M | $1.91B |
PN vs SOL vs ARRY vs CSIQ — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 25 | May 26 | Return |
|---|---|---|---|
| Skycorp Solar Group… (PN) | 100 | 11.1 | -88.9% |
| Emeren Group, Ltd. (SOL) | 100 | 110.2 | +10.2% |
| Array Technologies,… (ARRY) | 100 | 168.4 | +68.4% |
| Canadian Solar Inc. (CSIQ) | 100 | 204.4 | +104.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PN vs SOL vs ARRY vs CSIQ
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PN is the #2 pick in this set and the best alternative if value is your priority.
- Better valuation composite
SOL is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 0.33
- Lower volatility, beta 0.33, Low D/E 18.8%, current ratio 3.87x
- Beta 0.33, current ratio 3.87x
- Beta 0.33 vs ARRY's 2.32, lower leverage
ARRY is the clearest fit if your priority is growth exposure.
- Rev growth 40.2%, EPS growth 62.6%, 3Y rev CAGR -7.8%
- 40.2% revenue growth vs SOL's -12.8%
CSIQ carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 14.4% 10Y total return vs SOL's -67.9%
- -1.9% margin vs SOL's -7.5%
- +97.1% vs PN's -84.5%
- -0.7% ROA vs PN's -7.0%, ROIC -0.2% vs -10.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 40.2% revenue growth vs SOL's -12.8% | |
| Value | Better valuation composite | |
| Quality / Margins | -1.9% margin vs SOL's -7.5% | |
| Stability / Safety | Beta 0.33 vs ARRY's 2.32, lower leverage | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +97.1% vs PN's -84.5% | |
| Efficiency (ROA) | -0.7% ROA vs PN's -7.0%, ROIC -0.2% vs -10.8% |
PN vs SOL vs ARRY vs CSIQ — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PN vs SOL vs ARRY vs CSIQ — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SOL leads in 3 of 6 categories
ARRY leads 1 • CSIQ leads 1 • PN leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SOL leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CSIQ is the larger business by revenue, generating $5.6B annually — 88.4x PN's $63M. CSIQ is the more profitable business, keeping -1.9% of every revenue dollar as net income compared to SOL's -7.5%. On growth, SOL holds the edge at +21.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $63M | $71M | $1.2B | $5.6B |
| EBITDAEarnings before interest/tax | — | -$27M | $95M | $284M |
| Net IncomeAfter-tax profit | — | -$5M | -$67M | -$104M |
| Free Cash FlowCash after capex | — | $34M | $58M | -$1.7B |
| Gross MarginGross profit ÷ Revenue | +10.0% | +33.9% | +22.4% | +18.3% |
| Operating MarginEBIT ÷ Revenue | -4.0% | -49.8% | +4.5% | +0.1% |
| Net MarginNet income ÷ Revenue | -4.3% | -7.5% | -5.6% | -1.9% |
| FCF MarginFCF ÷ Revenue | +3.7% | +47.4% | +4.8% | -29.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +21.6% | -26.1% | -20.0% |
| EPS Growth (YoY)Latest quarter vs prior year | — | -27.7% | -7.0% | -3.7% |
Valuation Metrics
Evenly matched — PN and CSIQ each lead in 2 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, ARRY's 13.5x EV/EBITDA is more attractive than SOL's 17.6x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $10M | $100M | $1.3B | $1.2B |
| Enterprise ValueMkt cap + debt − cash | $7M | $113M | $1.8B | $7.0B |
| Trailing P/EPrice ÷ TTM EPS | -3.50x | -8.08x | -11.23x | -11.41x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 11.75x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 17.62x | 13.50x | — |
| Price / SalesMarket cap ÷ Revenue | 0.16x | 1.08x | 0.98x | 0.21x |
| Price / BookPrice ÷ Book value/share | 0.43x | 0.30x | 4.80x | 0.28x |
| Price / FCFMarket cap ÷ FCF | 4.28x | — | 15.72x | — |
Profitability & Efficiency
ARRY leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
SOL delivers a -1.6% return on equity — every $100 of shareholder capital generates $-2 in annual profit, vs $-21 for ARRY. SOL carries lower financial leverage with a 0.19x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARRY's 2.94x. On the Piotroski fundamental quality scale (0–9), ARRY scores 5/9 vs CSIQ's 1/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -13.1% | -1.6% | -20.6% | -2.5% |
| ROA (TTM)Return on assets | -7.0% | -1.2% | -4.4% | -0.7% |
| ROICReturn on invested capital | -10.8% | -0.1% | +9.0% | -0.2% |
| ROCEReturn on capital employed | -11.9% | -0.1% | +8.2% | -0.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 5 | 1 |
| Debt / EquityFinancial leverage | 0.26x | 0.19x | 2.94x | 1.80x |
| Net DebtTotal debt minus cash | -$4M | $13M | $522M | $5.8B |
| Cash & Equiv.Liquid assets | $9M | $50M | $244M | $1.9B |
| Total DebtShort + long-term debt | $6M | $63M | $766M | $7.7B |
| Interest CoverageEBIT ÷ Interest expense | -9.47x | -9.38x | -2.42x | 0.02x |
Total Returns (Dividends Reinvested)
CSIQ leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CSIQ five years ago would be worth $4,461 today (with dividends reinvested), compared to $957 for PN. Over the past 12 months, CSIQ leads with a +97.1% total return vs PN's -84.5%. The 3-year compound annual growth rate (CAGR) favors SOL at -21.2% vs PN's -54.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -46.8% | — | -15.3% | -30.4% |
| 1-Year ReturnPast 12 months | -84.5% | +37.6% | +62.7% | +97.1% |
| 3-Year ReturnCumulative with dividends | -90.4% | -51.0% | -56.1% | -52.3% |
| 5-Year ReturnCumulative with dividends | -90.4% | -76.6% | -67.7% | -55.4% |
| 10-Year ReturnCumulative with dividends | -90.4% | -67.9% | -77.5% | +14.4% |
| CAGR (3Y)Annualised 3-year return | -54.3% | -21.2% | -24.0% | -21.9% |
Risk & Volatility
SOL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SOL is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than ARRY's 2.32 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SOL currently trades 99.5% from its 52-week high vs PN's 8.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.34x | 0.33x | 2.32x | 2.23x |
| 52-Week HighHighest price in past year | $87.40 | $1.95 | $12.23 | $34.59 |
| 52-Week LowLowest price in past year | $0.46 | $1.38 | $4.92 | $8.84 |
| % of 52W HighCurrent price vs 52-week peak | +8.8% | +99.5% | +67.0% | +51.1% |
| RSI (14)Momentum oscillator 0–100 | 64.7 | 68.8 | 56.4 | 62.4 |
| Avg Volume (50D)Average daily shares traded | 2.0M | 609K | 6.0M | 2.5M |
Analyst Outlook
SOL leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: ARRY as "Buy", CSIQ as "Buy". Consensus price targets imply 63.3% upside for CSIQ (target: $29) vs 11.8% for ARRY (target: $9).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | $9.17 | $28.88 |
| # AnalystsCovering analysts | — | — | 28 | 33 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 2 | 1 | 0 |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +7.2% | 0.0% | +5.9% |
SOL leads in 3 of 6 categories (Income & Cash Flow, Risk & Volatility). ARRY leads in 1 (Profitability & Efficiency). 1 tied.
PN vs SOL vs ARRY vs CSIQ: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is PN or SOL or ARRY or CSIQ a better buy right now?
For growth investors, Array Technologies, Inc.
(ARRY) is the stronger pick with 40. 2% revenue growth year-over-year, versus -12. 8% for Emeren Group, Ltd. (SOL). Analysts rate Array Technologies, Inc. (ARRY) a "Buy" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — PN or SOL or ARRY or CSIQ?
Over the past 5 years, Canadian Solar Inc.
(CSIQ) delivered a total return of -55. 4%, compared to -90. 4% for Skycorp Solar Group Limited (PN). Over 10 years, the gap is even starker: CSIQ returned +14. 4% versus PN's -90. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — PN or SOL or ARRY or CSIQ?
By beta (market sensitivity over 5 years), Emeren Group, Ltd.
(SOL) is the lower-risk stock at 0. 33β versus Array Technologies, Inc. 's 2. 32β — meaning ARRY is approximately 612% more volatile than SOL relative to the S&P 500. On balance sheet safety, Emeren Group, Ltd. (SOL) carries a lower debt/equity ratio of 19% versus 3% for Array Technologies, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — PN or SOL or ARRY or CSIQ?
By revenue growth (latest reported year), Array Technologies, Inc.
(ARRY) is pulling ahead at 40. 2% versus -12. 8% for Emeren Group, Ltd. (SOL). On earnings-per-share growth, the picture is similar: Array Technologies, Inc. grew EPS 62. 6% year-over-year, compared to -747. 1% for Skycorp Solar Group Limited. Over a 3-year CAGR, SOL leads at 4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — PN or SOL or ARRY or CSIQ?
Canadian Solar Inc.
(CSIQ) is the more profitable company, earning -1. 9% net margin versus -13. 6% for Emeren Group, Ltd. — meaning it keeps -1. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ARRY leads at 6. 6% versus -4. 0% for PN. At the gross margin level — before operating expenses — SOL leads at 26. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is PN or SOL or ARRY or CSIQ more undervalued right now?
Analyst consensus price targets imply the most upside for CSIQ: 63.
3% to $28. 88.
07Which pays a better dividend — PN or SOL or ARRY or CSIQ?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is PN or SOL or ARRY or CSIQ better for a retirement portfolio?
For long-horizon retirement investors, Emeren Group, Ltd.
(SOL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 33)). Array Technologies, Inc. (ARRY) carries a higher beta of 2. 32 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SOL: -67. 9%, ARRY: -77. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between PN and SOL and ARRY and CSIQ?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PN is a small-cap high-growth stock; SOL is a small-cap quality compounder stock; ARRY is a small-cap high-growth stock; CSIQ is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.